These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 9143298)

  • 21. Inoculation with DNA encoding the glycoprotein gp2 reduces severity of equine herpesvirus 1 infection in a mouse respiratory model.
    Learmonth GS; Love DN; Gilkerson JR; Wellington JE; Whalley JM
    Arch Virol; 2003 Sep; 148(9):1805-13. PubMed ID: 14505091
    [TBL] [Abstract][Full Text] [Related]  

  • 22. EHV-1 glycoprotein D (EHV-1 gD) is required for virus entry and cell-cell fusion, and an EHV-1 gD deletion mutant induces a protective immune response in mice.
    Csellner H; Walker C; Wellington JE; McLure LE; Love DN; Whalley JM
    Arch Virol; 2000; 145(11):2371-85. PubMed ID: 11205124
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunization with Attenuated Equine Herpesvirus 1 Strain KyA Induces Innate Immune Responses That Protect Mice from Lethal Challenge.
    Kim SK; Shakya AK; O'Callaghan DJ
    J Virol; 2016 Sep; 90(18):8090-104. PubMed ID: 27356904
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Equine herpesvirus type 1 modified live virus vaccines: quo vaditis?
    Rosas CT; Goodman LB; von Einem J; Osterrieder N
    Expert Rev Vaccines; 2006 Feb; 5(1):119-31. PubMed ID: 16451114
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibody and cellular immune responses following DNA vaccination and EHV-1 infection of ponies.
    Soboll G; Hussey SB; Whalley JM; Allen GP; Koen MT; Santucci N; Fraser DG; Macklin MD; Swain WF; Lunn DP
    Vet Immunol Immunopathol; 2006 May; 111(1-2):81-95. PubMed ID: 16549215
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Equine herpesvirus 1 glycoprotein D expressed in Pichia pastoris is hyperglycosylated and elicits a protective immune response in the mouse model of EHV-1 disease.
    Ruitenberg KM; Gilkerson JR; Wellington JE; Love DN; Whalley JM
    Virus Res; 2001 Nov; 79(1-2):125-35. PubMed ID: 11551653
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quantitation of virus-specific classes of antibodies following immunization of mice with attenuated equine herpesvirus 1 and viral glycoprotein D.
    Zhang Y; Smith PM; Jennings SR; O'Callaghan DJ
    Virology; 2000 Mar; 268(2):482-92. PubMed ID: 10704356
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of secreted glycoprotein G of equine herpesvirus type 1 and type 4 (EHV-1 and EHV-4) in immune modulation and virulence.
    Thormann N; Van de Walle GR; Azab W; Osterrieder N
    Virus Res; 2012 Oct; 169(1):203-11. PubMed ID: 22902480
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytokine responses to EHV-1 infection in immune and non-immune ponies.
    Coombs DK; Patton T; Kohler AK; Soboll G; Breathnach C; Townsend HG; Lunn DP
    Vet Immunol Immunopathol; 2006 May; 111(1-2):109-16. PubMed ID: 16473413
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kinetics of cytokine expression and regulation of host protection following infection with molecularly cloned Venezuelan equine encephalitis virus.
    Grieder FB; Davis BK; Zhou XD; Chen SJ; Finkelman FD; Gause WC
    Virology; 1997 Jul; 233(2):302-12. PubMed ID: 9217054
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The equine immune response to equine herpesvirus-1: the virus and its vaccines.
    Kydd JH; Townsend HG; Hannant D
    Vet Immunol Immunopathol; 2006 May; 111(1-2):15-30. PubMed ID: 16476492
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterisation of CTL and IFN-gamma synthesis in ponies following vaccination with a NYVAC-based construct coding for EHV-1 immediate early gene, followed by challenge infection.
    Paillot R; Ellis SA; Daly JM; Audonnet JC; Minke JM; Davis-Poynter N; Hannant D; Kydd JH
    Vaccine; 2006 Mar; 24(10):1490-500. PubMed ID: 16269205
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pathogenicity of a thymidine kinase-deficient mutant of equine herpesvirus 1 in mice and specific pathogen-free foals.
    Slater JD; Gibson JS; Field HJ
    J Gen Virol; 1993 May; 74 ( Pt 5)():819-28. PubMed ID: 8388018
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The truncated form of glycoprotein gp2 of equine herpesvirus 1 (EHV-1) vaccine strain KyA is not functionally equivalent to full-length gp2 encoded by EHV-1 wild-type strain RacL11.
    von Einem J; Wellington J; Whalley JM; Osterrieder K; O'Callaghan DJ; Osterrieder N
    J Virol; 2004 Mar; 78(6):3003-13. PubMed ID: 14990719
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of the gene 71 product in the life cycle of equine herpesvirus 1.
    Sun Y; MacLean AR; Aitken JD; Brown SM
    J Gen Virol; 1996 Mar; 77 ( Pt 3)():493-500. PubMed ID: 8601787
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Attenuation of a vaccine strain of vaccinia virus via inactivation of interferon viroceptor.
    Dénes B; Gridley DS; Fodor N; Takátsy Z; Timiryasova TM; Fodor I
    J Gene Med; 2006 Jul; 8(7):814-23. PubMed ID: 16634110
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An Argentine equine herpesvirus strain with special restriction patterns protect mice challenged with a pathogenic strain.
    Galosi CM; Barbeito CG; Martin Ocampos GP; Martinez JP; Ayala MA; Corva SG; Fuentealba NA; Gimeno EJ
    J Vet Med B Infect Dis Vet Public Health; 2006 Nov; 53(9):412-7. PubMed ID: 17062117
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of phoP and rpoS mutants of Salmonella enterica serovar Typhi as attenuated typhoid vaccine candidates: virulence and protective immune responses in intranasally immunized mice.
    Lee HY; Cho SA; Lee IS; Park JH; Seok SH; Baek MW; Kim DJ; Lee SH; Hur SJ; Ban SJ; Lee YK; Han YK; Cho YK; Park JH
    FEMS Immunol Med Microbiol; 2007 Nov; 51(2):310-8. PubMed ID: 17725620
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Live-attenuated recombinant equine herpesvirus type 1 (EHV-1) induces a neutralizing antibody response against West Nile virus (WNV).
    Rosas CT; Tischer BK; Perkins GA; Wagner B; Goodman LB; Osterrieder N
    Virus Res; 2007 Apr; 125(1):69-78. PubMed ID: 17241683
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of the full-length form of gp2 of equine herpesvirus 1 (EHV-1) completely restores respiratory virulence to the attenuated EHV-1 strain KyA in CBA mice.
    Smith PM; Kahan SM; Rorex CB; von Einem J; Osterrieder N; O'Callaghan DJ
    J Virol; 2005 Apr; 79(8):5105-15. PubMed ID: 15795295
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.